878745-51-8

Basic information

• Product Name: METHYL 2-TRIFLUOROMETHYL-4-PYRIMIDINE CARBOXYLATE
• Synonyms: METHYL 2-TRIFLUOROMETHYL-4-PYRIMIDINE CARBOXYLATE;Methyl2-(trifluoromethyl)pyrimidine-4-carBoxylate;2-Trifluoromethyl-pyrimidine-4-carboxylic acid methyl ester;4-(Methoxycarbonyl)-2-(trifluoromethyl)pyrimidine, 4-(Methoxycarbonyl)-2-(trifluoromethyl)-1,3-diazine;pyrimidine-4-carboxylate
• CAS NO: 878745-51-8
• Molecular Formula: C7H5F3N2O2
• Molecular Weight: 206.12
• Product Categories: pyrimidine
• Mol File: 878745-51-8.mol

Chemical Properties

• Boiling Point: 163.8ºC at 760 mmHg
• Flash Point: 52.9ºC
• Appearance: /
• Density: 1.29g/cm3
• Vapor Pressure: 2.66mmHg at 25°C
• Refractive Index: 1.436
• Storage Temp.: 2-8°C
• CAS DataBase Reference: METHYL 2-TRIFLUOROMETHYL-4-PYRIMIDINE CARBOXYLATE(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL 2-TRIFLUOROMETHYL-4-PYRIMIDINE CARBOXYLATE(878745-51-8)
• EPA Substance Registry System: METHYL 2-TRIFLUOROMETHYL-4-PYRIMIDINE CARBOXYLATE(878745-51-8)

Safety Data

• Hazard Codes: Xi
• Hazardous Substances Data: 878745-51-8(Hazardous Substances Data)

Usage

Uses

Methyl 2-(trifluoromethyl)pyrimidine-4-carboxylate is used as pharmaceutical intermediate.

InChI:InChI=1/C8H9F3N2O2/c1-14-6(15-2)5-3-4-12-7(13-5)8(9,10)11/h3-4,6H,1-2H3

Upstream product

• 67-56-1 methanol 
• 201230-82-2 carbon monoxide 
• 1514-96-1 4-chloro-2-(trifluoromethyl)pyrimidine 

Downstream Products

• 914348-10-0 2-(trifluoromethyl)pyrimidine-4-carboxamide 
• 878742-59-7 2-(trifluoromethyl)pyrimidine-4-carboxylic acid 
• 1192801-32-3 3-[1-methyl-1-(2-trifluoromethyl-pyrimidin-4-yl)-ethylamino]-1-(4-trifluoromethoxyphenyl)-5-(R)-(3-fluoro-phenyl)-1,5-dihydro-pyrrol-2-one 
• 1192801-13-0 (3R,5R)-3-[1-methyl-1-(2-trifluoromethyl-pyrimidin-4-yl)-ethylamino]-5-(3-fluoro-phenyl)-1-(4-trifluoromethoxy-phenyl)-pyrrolidin-2-one 
• 1192801-29-8 (R)-3-[1-methyl-1-(2-trifluoromethyl-pyrimidin-4-yl)-ethylamino]-1-(4-trifluoromethyl-phenyl)-5-(3-trifluoromethoxy-phenyl)-1,5-dihydro-pyrrol-2-one 
• 1192801-11-8 (3R,5R)-3-[1-methyl-1-(2-trifluoromethyl-pyrimidin-4-yl)-ethylamino]-5-(3-trifluoromethoxy-phenyl)-1-(4-trifluoromethyl-phenyl)-pyrrolidin-2-one 

Relevant articles and documents

IRAK DEGRADERS AND USES THEREOF

The present invention provides compounds, compositions thereof, and methods of using the same.

IRAK DEGRADERS AND USES THEREOF

The present invention provides compounds, compositions thereof, and methods of using the same.

IRAK DEGRADERS AND USES THEREOF

The present invention provides compounds, compositions thereof, and methods of using the same. The compounds include an IRAK binding moiety capable of binding to IRAK4 and a degradation inducing moiety (DIM). The DIM could be DTM a ligase binding moiety (LBM) or lysine mimetic. The compounds could be useful as IRAK protein kinase inhibitors and applied to IRAK mediated disorders.

KCNT1 INHIBITORS AND METHODS OF USE

The present invention is directed to, in part, compounds and compositions useful for preventing and/or treating a neurological disease or disorder, a disease or condition relating to excessive neuronal excitability, and/or a gain-of-function mutation in a gene (e.g., KCNT1). Methods of treating a neurological disease or disorder, a disease or condition relating to excessive neuronal excitability, and/or a gain-of-function mutation in a gene such as KCNT1 are also provided herein.

THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE

Provided are compounds useful for treating cancer and methods of treating cancer comprising administering to a subject in need thereof a compound described herein.

THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE

Provided are compounds useful for treating cancer and methods of treating cancer comprising administering to a subject in need thereof a compound described herein.